Pko Investment Management Joint Stock CO Vertex Pharmaceuticals Inc Transaction History

Pko Investment Management Joint Stock CO

$882 Billion
Q1 2025

A detailed history of Pko Investment Management Joint Stock CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 1,800 shares of VRTX stock, worth $795,582. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,800

Previous 7,600 76.32%

Holding current value

$795,582

Previous $3.06 Billion 71.49%

% of portfolio

0.1%

Previous 0.38%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$402.49 - $513.76 $2.33 Million - $2.98 Million	-5,800 Reduced 76.32%	1,800 $873 Million
Q4 2024 Mar 13, 2025	BUY	$396.64 - $516.74 $3.01 Million - $3.93 Million	7,600 New	7,600 $3.06 Billion
Q3 2024 Mar 13, 2025	SELL	$460.0 - $505.78 $1.47 Million - $1.62 Million	-3,200 Reduced 64.0%	1,800 $837 Million
Q2 2024 Mar 13, 2025	SELL	$392.81 - $485.53 $1.57 Million - $1.94 Million	-4,000 Reduced 80.0%	1,000 $469 Million
Q1 2024 Mar 13, 2025	SELL	$407.69 - $446.08 $1.06 Million - $1.16 Million	-2,600 Reduced 34.21%	5,000 $2.1 Billion
Q4 2023 Mar 13, 2025	SELL	$343.0 - $410.68 $891,800 - $1.07 Million	-2,600 Reduced 34.21%	5,000 $2.03 Billion
Q2 2023 Mar 13, 2025	SELL	$314.42 - $351.91 $628,840 - $703,820	-2,000 Closed	0 $0
Q1 2023 Mar 13, 2025	BUY	$283.23 - $323.1 $226,584 - $258,480	800 Added 66.67%	2,000 $630 Million
Q3 2022 Mar 13, 2025	SELL	$273.83 - $305.53 $1.75 Million - $1.96 Million	-6,400 Reduced 84.21%	1,200 $347 Million
Q2 2022 Mar 13, 2025	SELL	$234.96 - $292.55 $305,448 - $380,315	-1,300 Reduced 52.0%	1,200 $338 Million
Q1 2022 Mar 13, 2025	SELL	$221.42 - $260.97 $996,390 - $1.17 Million	-4,500 Reduced 64.29%	2,500 $652 Million
Q4 2021 Mar 13, 2025	SELL	$177.01 - $223.45 $106,206 - $134,070	-600 Reduced 7.89%	7,000 $1.54 Billion

Others Institutions Holding VRTX

# of Institutions

1,833

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.

Account

Pko Investment Management Joint Stock CO Vertex Pharmaceuticals Inc Transaction History